Skip to main content
Uncategorized

Bioglane, Bionure and Omnia seek funding at Healthcare Barcelona Investment Forum

By 25 de May de 2012November 18th, 2020No Comments
< Back to news
 25.05.2012

Bioglane, Bionure and Omnia seek funding at Healthcare Barcelona Investment Forum

The seventh Healthcare Barcelona Investment Forum was held today under the framework of MIHealth, an international congress on clinical innovation and its impact on healthcare management. Some forty applications were received from around Spain, from which a panel of judges selected the 10 companies with the highest potential for growth and that best fit the needs of the investors in this edition. Bioglane, Bionure and Omnia Molecular –based in the Barcelona Science Park–are three of the selected projects.


The Healthcare Barcelona Investment Forum —driven by the Barcelona Medical Association (COMB), IESE, Barcelona Activa, Biocat and Fira de Barcelona— offers companies and entrepreneurs with projects in biotechnology, medical devices, healthcare services and information technology applied to health with a high potential for growth the opportunity to present these projects to investors from the sector and from the Iese Private Investors and Family Offices Network.

The Forum aims to improve access to private funding for companies that need an injection of capital of up to €2 millions. Each company had twenty minutes to present their business project to the investors.

Image: SOM Biotech presentation at the sixth Healthcare Barcelona Investment Forum